The sting challenge test in Hymenoptera venom allergy: Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 4, 1996, Pages 216-225

  Rueff F ^a   Przybilla, B ^a   Muller U ^b   Mosbech, H ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b Spital Netz Bern   (Switzerland)

^c University of Copenhagen   (Denmark)

Author keywords

Hymenoptera venom allergy; Sting challenge

Indexed keywords

BEE; BEE STING; DIAGNOSTIC VALUE; ENVENOMATION; INSECT ALLERGY; MEDICAL ETHICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RISK FACTOR;

ANIMALS; ARTHROPOD VENOMS; HUMANS; HYMENOPTERA; IMMUNOTHERAPY, ACTIVE; INSECT BITES AND STINGS;

EID: 0029884624     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04596.x     Document Type: Article

References (79)

1. Charpin D, Birnbaum J, Lanteaume A, Vervloet D. Prevalence of allergy to Hymenoptera stings in different samples of the general population. J Allergy Clin Immunol 1992;90:331-4.
2. Golden DBK, Valentine MD, Kagey-Sobotka A, Lichtenstein LM. Prevalence of Hymenoptera venom allergy. J Allergy Clin Immunol 1982;69:124.
3. Müller UR. Insect sting allergy: clinical picture, diagnosis and treatment. Stuttgart: Gustav Fischer, 1990.
4. Barnard JH. Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973;52:259-64.
5. Mosbech H. Death caused by wasp and bee stings in Denmark 1960-1980. Allergy 1983;38:195-200.
6. Müller U, Mosbech H. Position paper. Immunotherapy with Hymenoptera venoms. Allergy 1993;48 Suppl 14:37-46.
7. Przybilla B, Ring J. Hymenoptera venom allergy. In: Ring J, Przybilla B, editors. New trends in allergy. Berlin: Springer, 1991:335-49.
8. Blaauw PJ, Smithuis LOMJ. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital sting. J Allergy Clin Immunol 1985;75:556-62.
9. Forster J, Hauck P, Urbanek R. Sequential bee sting challenge (SBSC) before hyposensitization therapy (HST) in children with bee venom allergy (BVA). J Allergy Clin Immunol 1991;87:238.
10. Franken HH, Dubois AEJ, Minkema HJ, van der Heide S, De Monchy JGR. Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunology 1994;93:431-6.
11. Kampelmacher MJ, van der Zwan JC. Provocation test with a living insect as a diagnostic tool in systemic reactions to bee and wasp venom: a prospective study with emphasis on the clinical aspects. Clin Allergy 1987;17:317-27.
12. van der Linden P-WG, Hack CE, Poortman J, Vivie-Kipp YC, Struyvenberg A, van der Zwan JK. Insect-sting challenge in 138 patients: relation between clinical severity of anaphylaxis and mast cell activation. J Allergy Clin Immunol 1992;90:101-8.
13. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein MD. A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978;299:157-61.
14. Day JH, Buckeridge DL, Welsh AC. Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals. J Allergy Clin Immunol 1994; 93:691-705.
15. Engel T, Heinig JH, Weeke ER. Prognosis of patients reacting with urticaria to insect sting. Allergy 1988;43:289-93.
16. Parker JL, Santrach PJ, Dahlberg JE, Yunginger JW. Evaluation of Hymenoptera-sting sensitivity with deliberate sting challenges: inadequacy of present diagnostic methods. J Allergy Clin Immunol 1982;96:200-7.
17. van der Linden P-WG, Hack CE, Struyvenberg A, van der Zwan JC. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis. J Allergy Clin Immunol 1994;94:151-9.
18. Bäurle G, Schwarz W. Hymenopterengift-Allergie. Stellenwert des allergenspezifischen IgG bei der Therapie. Dtsch Med Wochenschr 1983;108:1351-5.
19. Chipps BE, Valentine MD, Kagey-Sobotka A, Schuberth KC, Lichtenstein LM. Diagnosis and treatment of anaphylactic reactions to Hymenoptera stings in children. J Pediatr 1980;97:177-84.
20. Gillman SA, Cummins LH, Kozak PP, Hoffman DR. Venom immunotherapy: comparison of "rush" vs "conventional" schedules. Ann Allergy 1980;45:351-4.
21. Goldberg A, Confino-Cohen R, Mekori Y. Deliberate bee sting challenge of patients receiving maintenance venom immunotherapy at 3-month intervals. J Allergy Clin Immunol 1994;93:997-1001.
22. Golden DBK, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Dose-dependence of Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1981;67:370-4.
23. Golden DBK, Lawrence ID, Hamilton RH, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy. J Allergy Clin Immunol 1992; 90:386-93.
24. Hoffman DR, Gillman SA, Cummins LH, Kozak PP, Oswald A. Correlation of IgG and IgE antibody levels to honeybee venom allergens with protection to sting challenge. Ann Allergy 1981;46:17-23.
25. Mosbech H, Mailing H-J, Biering I, et al. Immunotherapy with yellow jacket venom. Allergy 1986;41:95-103.
26. Müller U, Helbling A, Bischof M. Predictive value of venom specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honeybee venom. Allergy 1989;44:412-18.
27. Müller U, Helbling A, Berchtold E. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J Allergy Clin Immunol 1992;89:529-35.
28. Nataf P, Guinnepain MT, Herman D. Rush venom immunotherapy: a 3-day programme for Hymenoptera sting allergy. Clin Allergy 1984;14:269-75.
29. Przybilla B, Ring J. Grießhammer B, Braun-Falco O. Schnellhyposensibilisierung mit Hymenopterengiften. Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr 1987;112:416-24.
30. Urbanek R, Forster J, Kuhn W, Ziupa J. Discontinuation of bee venom immunotherapy in children and adolescents. J Pediatr 1985;107:367-71.
31. Urbanek R, Kemeny DM, Richards D. Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy. Clin Allergy 1986;16:317-22.
32. van der Zwan JC, Flinterman J, Jankowski G, Kerckhaert JAM. Hyposensitization to wasp venom in 6 hours. BMJ 1983;287:1329-31.
33. Yunginger JW. The sting revisited. J Allergy Clin Immunol 1979;64:1-2.
34. Golden DBK, Addison BI, Gadde J, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Prospective observations on stopping prolonged venom immunotherapy. J Allergy Clin Immunol 1989;84:162-7.
35. Golden DBK, Kwiterovich KA, Kagey-Sobotka A, Valentine MD, Lichtenstein LM. Discontinuing venom immunotherapy (VIT): determinants of clinical reactivity. J Allergy Clin Immunol 1989;83:273.
36. Haugaard L, Norregaard OFH, Dahl R. In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 1991; 87:699-702.
37. Keating MU, Kagey-Sobotka A, Hamilton RG, Yunginger JW. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol 1991;88:339-48.
38. Müller U, Berchtold E, Helbling A. Honeybee venom allergy: results of a sting challenge 1 year after stopping successful immunotherapy in 86 patients. J Allergy Clin Immunol 1991;87:702-9.
39. Eberlein-König B, Ullmann S, Thomas P, Przybilla B. Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy 1995; 25:704-12.
40. Hauk PJ, Otto J, Urbanek R. Histaminfreisetzung und Nachweis von Histaminmetaboliten nach Stichexposition bei Kindern mit Sensibilisierung auf Bienengift. Allergologie (Beiheft) 1990;13:11-12.
41. Hauk P, Otto J, Schwab O, Forster J, Urbanek R. Katecholaminfreisetzung im Blut nach Insektenstich-Provokationen. Allergologie 1991;14:73.
42. Smith PL, Kagey-Sobotka A, Bleecker ER, et al. Physiologic manifestations of human anaphylaxis. J Clin Invest 1980;66:1072-80.
43. van der Linden PWG, Hack CE, Kerckhaert JAM, Struyvenberg A, van der Zwan JC. Preliminary report: complement activation in wasp-sting anaphylaxis. Lancet 1990;336:904-6.
44. van der Linden P-WG, Struyvenberg A, Kraaijenhagen RJ, Hack CE, van der Zwan JC. Anaphylactic shock after insect-sting challenge in 138 persons with a previous insect-sting reaction. Ann Int Med 1993;118:161-8.
45. Bousquet J, Menardo JL, Velasquez G, Michel FB. Systemic reactions during maintenance immunotherapy with honey bee venom. Ann Allergy 1988;61:63-8.
46. Jarisch R. Die Bienengiftallergie (Modell einer IgE-mediierten Soforttypallergie). Wien Klin Wochenschr 1980;92 Suppl 122:3-27.
47. Lichtenstein LM, Valentine MD, Sobotka AK. Insect allergy: the state of the art. J Allergy Clin Immunol 1979;64:5-12.
48. Menardo JL, Bousquet J, Delair L, Michel FB. Treatment failures during maintenance therapy in honey bee venom allergy. J Allergy Clin Immunol 1984;73:188.
49. Przybilla B, Ring J. Hyposensibilisierungsbehandlung der Hymenopterengiftallergie: Aspekte der Indikationsstellung und Dosierung. Allergologie (Beiheft) 1986;9:2-10.
50. Bauer CP. Stichprovokationen zur Diagnostik von Insektengift-Allergien? Allergologie 1986;9:14.
51. Golden DBK, Johnson K, Addison BI, et al. Evolution of Hymenoptera venom allergy. J Allergy Clin Immunol 1984;73:189.
52. Golden DBK, Addison BI, Kwiterovich KA, et al. Natural history of Hymenoptera venom allergy (HVA) in adults. J Allergy Clin Immunol 1992;89:291.
53. Heinig JH, Engel T, Weeke ER. Allergy to venom from bee or wasp: the relation between clinical and immunological reactions to insect stings. Clin Allergy 1988;18:71-8.
54. Schuberth KC, Kagey-Sobotka A, Kwiterovich K, et al. A comparison of venom treatment and no treatment in insect allergic children. J Allergy Clin Immunol 1982;69:124.
55. Hoffman DR, Jacobsen RS. Allergens in Hymenoptera venom. XII. How much protein is in a sting? Ann Allergy 1984;52:276-8.
56. Schumacher MJ, Tveten MS, Egen NB. Rate and quantity of delivery of venom from honeybee stings. J Allergy Clin Immunol 1994;93:831-5.
57. Lantner R, Reisman RE. Clinical and immunological features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 1989;84:900-6.
58. Peppe BC, Lockey RF, Madden EE, Baird I, Turkeltaub P. Hymenoptera venom study (HVS), treatment results. J Allergy Clin Immunol 1983;71:120.
59. Przybilla B, Ring J, Rieger B. Die Indikation zur Hymenopterengift-Hyposensibilisierung kann nicht anhand eines diagnostischen Parameter bewertenden Punkteschemas gestellt werden. Allergologie 1992;13:114-19.
60. Reisman RE, Dvorin J, Randolph CC, Georgitis JW. Stinging insect allergy: natural history and modification with venom immunotherapy. J Allergy Clin Immunol 1985;76:735-40.
61. Reisman RE. Natural history of insect-sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions. J Allergy Clin Immunol 1992;90:335-9.
62. Savliwala MN, Reisman RE. Studies of the natural history of stinging-insect allergy: long-term follow-up of patients without immunotherapy. J Allergy Clin Immunol 1987; 80:741-5.
63. Schuberth KC, Lichtenstein LM, Kagey-Sobotka A, Szklo M, Kwiterovich KA, Valentine MD. Epidemiologic study of insect allergy in children. II. Effect of accidental stings in allergic children. J Pediatr 1983;102:361-5.
64. Settipane GA, Chafee FH. Natural history of allergy to Hymenoptera. Clin Allergy 1979;9:385-90.
65. Valentine MD, Schuberth KC, Kagey-Sobotka A, et al. The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990;323:1601-3.
66. Bousquet J, Knani J, Velasquez G, Menardo JL, Guilloux L, Michel FB. Evolution of sensitivity to Hymenoptera venom in 200 allergic patients followed for up to 3 years. J Allergy Clin Immunol 1989;84:944-50.
67. Graft DF, Schuberth KC, Kagey-Sobotka A, et al. Assessment of prolonged venom immunotherapy in children. J Allergy Clin Immunol 1987;80:162-6.
68. Grant JA, Goldblum RM, Rahr R, Thueson DO, Farnam J, Gillaspy J. Enzyme-linked immunosorbent assay (ELISA) for immunoglobulin G antibodies against insect venoms. J Allergy Clin Immunol 1981;68:112-18.
69. Livingston A, Reisman R. Venom immunotherapy (VIT): ten years' experience with administration of single venoms and fifty microgram maintenance doses. J Allergy Clin Immunol 1990;85:210.
70. Mokry L, Wüthrich B, Dietschi R. Zur kausalen Behandlung der Hymenopterenstichallergie. Schweiz Rundschau Med 1985;38:1005-16.
71. Müller U, Thurnheer U, Patrizzi R, Spiess J, Hoigne R. Immunotherapy in bee sting hypersensitivity. Allergy 1979;34:369-78.
72. Randolph CC, Georgitis JW, Reisman RE. Clinical and immunologic response to long-term venom immunotherapy. J Allergy Clin Immunol 1984;73:140.
73. Thurnheer U, Müller U, Stoller R, Lanner A, Hoigne R. Venom immunotherapy in Hymenoptera sting allergy. Comparison of rush and conventional hyposensitization and observations during long-term treatment. Allergy 1983;38:465-73.
74. Wyss M, Scheitlin T, Stadler BM, Wüthrich B. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy 1993;48:81-6.
75. Reisman RE. Intentional diagnostic insect sting challenges: a medical and ethical issue. J Allergy Clin Immunol 1993;91:1100.
76. Owen MD, Bridges AR. Aging in the venom glands of queen and worker honey bees (Apis mellifera L.): some morphological and chemical observations. Toxicon 1976;14:1-5.
77. Owen MD. Relationship between age and hyaluronidase activity in the venom of queen and worker honey bees (Apis mellifera L.). Toxicon 1978;17:94-8.
78. Reisman RE, Livingston A. Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 1989;84:331-7.
79. Müller U, Mosbech H, Blaauw PJ, et al. Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy 1991;21:281-8.